The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14683
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 3, 2017
Authors
Publisher
Wiley